Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

Medicine, Oncology, Breast Oncology +6

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

New England Journal of Medicine · 2005 · 1.6K citations · Full text

Medicine, Gynecology, Obstetrics +9

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao et al. · Journal of Clinical Oncology · 2010 · 829 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer

Ann H. Partridge, Philip S. Wang, Eric P. Winer et al. · Journal of Clinical Oncology · 2003 · 680 citations

Medicine, Oncology, Pharmacotherapy +12

ATAC trial update

Anthony Howell · The Lancet · 2005 · 397 citations · Full text